Mrs Latanya Wood El, RN in Magnolia, NJ - Registered Nurse

Mrs Latanya Wood El, RN is a Registered Nurse based in Magnolia, New Jersey. Mrs Latanya Wood El is licensed to practice in New Jersey (license number 26NO07408100) and her current practice location is 212 E Madison Ave, Magnolia, New Jersey. She can be reached at her office (for appointments etc.) via phone at (856) 602-4838.

NPI number for Mrs Latanya Wood El is 1245685825 and her current mailing address is 212 E Madison Ave, Magnolia, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1245685825.

Contact Information

	Mrs Latanya Wood El, RN
	212 E Madison Ave, Magnolia, NJ 08049-1409
	(856) 602-4838
	Not Available

Provider's Profile

Full Name	Mrs Latanya Wood El
Gender	Female
Speciality	Registered Nurse
Location	212 E Madison Ave, Magnolia, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1245685825
Provider Enumeration Date: 05/02/2016
Last Update Date: 05/02/2016

Medical Identifiers

Medical identifiers for Mrs Latanya Wood El such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1245685825	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	26NO07408100 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Latanya Wood El is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Latanya Wood El, RN 212 E Madison Ave, Magnolia, NJ 08049-1409 Ph: (856) 602-4838	Mrs Latanya Wood El, RN 212 E Madison Ave, Magnolia, NJ 08049-1409 Ph: (856) 602-4838

News Archive

NIH Chief Francis Collins: Medical research 'ought to tell us what works'

Kaiser Health News staff writer Jennifer Evans talked to physician-geneticist Francis Collins, a person "who isn't afraid to think big about science. For over a decade, Collins led the Human Genome Project, overseeing the federal government's race to map people's DNA.

Two common cancer drugs prevent, reverse type 1 diabetes

Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco.

TOPROL-XL and metoprolol succinate are available for patients in all regions across the country: AstraZeneca

Following published reports that two generic companies had recalled or suspended shipments of metoprolol succinate, a beta-blocker medication taken by over half a million Americans for the treatment of high blood pressure, TOPROL-XL and its authorized generic, metoprolol succinate extended-release tablets are available.

Selcia announces drug discovery collaboration agreement with Gilead Sciences

Selcia Limited, a leading contract research organisation, today announced a drug discovery collaboration agreement with Gilead Sciences, Inc. (Foster City, California).

Mrs Latanya Wood El, RN - Registered Nurse in Magnolia, NJ